Covalent Inhibition of Wild-Type HIV-1 Reverse Transcriptase Using a Fluorosulfate Warhead. 2021

Joseph A Ippolito, and Haichan Niu, and Nicole Bertoletti, and Zachary J Carter, and Shengyan Jin, and Krasimir A Spasov, and José A Cisneros, and Margarita Valhondo, and Kara J Cutrona, and Karen S Anderson, and William L Jorgensen
Department of Chemistry, Yale University, New Haven, Connecticut 06520-8107, United States.

Covalent inhibitors of wild-type HIV-1 reverse transcriptase (CRTIs) are reported. Three compounds derived from catechol diether non-nucleoside inhibitors (NNRTIs) with addition of a fluorosulfate warhead are demonstrated to covalently modify Tyr181 of HIV-RT. X-ray crystal structures for complexes of the CRTIs with the enzyme are provided, which fully demonstrate the covalent attachment, and confirmation is provided by appropriate mass shifts in ESI-TOF mass spectra. The three CRTIs and six noncovalent analogues are found to be potent inhibitors with both IC50 values for in vitro inhibition of WT RT and EC50 values for cytopathic protection of HIV-1-infected human T-cells in the 5-320 nM range.

UI MeSH Term Description Entries

Related Publications

Joseph A Ippolito, and Haichan Niu, and Nicole Bertoletti, and Zachary J Carter, and Shengyan Jin, and Krasimir A Spasov, and José A Cisneros, and Margarita Valhondo, and Kara J Cutrona, and Karen S Anderson, and William L Jorgensen
November 2023, RSC chemical biology,
Joseph A Ippolito, and Haichan Niu, and Nicole Bertoletti, and Zachary J Carter, and Shengyan Jin, and Krasimir A Spasov, and José A Cisneros, and Margarita Valhondo, and Kara J Cutrona, and Karen S Anderson, and William L Jorgensen
February 1996, Protein expression and purification,
Joseph A Ippolito, and Haichan Niu, and Nicole Bertoletti, and Zachary J Carter, and Shengyan Jin, and Krasimir A Spasov, and José A Cisneros, and Margarita Valhondo, and Kara J Cutrona, and Karen S Anderson, and William L Jorgensen
September 2012, Physical chemistry chemical physics : PCCP,
Joseph A Ippolito, and Haichan Niu, and Nicole Bertoletti, and Zachary J Carter, and Shengyan Jin, and Krasimir A Spasov, and José A Cisneros, and Margarita Valhondo, and Kara J Cutrona, and Karen S Anderson, and William L Jorgensen
January 2001, Nucleosides, nucleotides & nucleic acids,
Joseph A Ippolito, and Haichan Niu, and Nicole Bertoletti, and Zachary J Carter, and Shengyan Jin, and Krasimir A Spasov, and José A Cisneros, and Margarita Valhondo, and Kara J Cutrona, and Karen S Anderson, and William L Jorgensen
December 2002, Bioorganic chemistry,
Joseph A Ippolito, and Haichan Niu, and Nicole Bertoletti, and Zachary J Carter, and Shengyan Jin, and Krasimir A Spasov, and José A Cisneros, and Margarita Valhondo, and Kara J Cutrona, and Karen S Anderson, and William L Jorgensen
February 2009, European journal of medicinal chemistry,
Joseph A Ippolito, and Haichan Niu, and Nicole Bertoletti, and Zachary J Carter, and Shengyan Jin, and Krasimir A Spasov, and José A Cisneros, and Margarita Valhondo, and Kara J Cutrona, and Karen S Anderson, and William L Jorgensen
January 1998, Antiviral therapy,
Joseph A Ippolito, and Haichan Niu, and Nicole Bertoletti, and Zachary J Carter, and Shengyan Jin, and Krasimir A Spasov, and José A Cisneros, and Margarita Valhondo, and Kara J Cutrona, and Karen S Anderson, and William L Jorgensen
November 1993, Biochemistry,
Joseph A Ippolito, and Haichan Niu, and Nicole Bertoletti, and Zachary J Carter, and Shengyan Jin, and Krasimir A Spasov, and José A Cisneros, and Margarita Valhondo, and Kara J Cutrona, and Karen S Anderson, and William L Jorgensen
December 1990, Science (New York, N.Y.),
Joseph A Ippolito, and Haichan Niu, and Nicole Bertoletti, and Zachary J Carter, and Shengyan Jin, and Krasimir A Spasov, and José A Cisneros, and Margarita Valhondo, and Kara J Cutrona, and Karen S Anderson, and William L Jorgensen
January 1999, Antiviral therapy,
Copied contents to your clipboard!